
ICUI
ICU Medical Inc.
$127.66
+$0.62(+0.49%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$3.11B
Volume
229.50K
52W Range
$107.00 - $196.26
Target Price
$174.00
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $341.7M | $379.4M | $1.3B | $1.4B | $1.3B | $1.3B | $1.3B | $2.3B | $2.3B | $2.4B | ||
Total Revenue | $341.7M | $379.4M | $1.3B | $1.4B | $1.3B | $1.3B | $1.3B | $2.3B | $2.3B | $2.4B | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $160.9M | $178.0M | $-866.5M | $-830.0M | $794.3M | $809.5M | $824.8M | $1.6B | $1.5B | $1.6B | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $180.8M | $201.4M | $426.1M | $570.0M | $471.9M | $461.5M | $491.5M | $697.8M | $739.9M | $824.8M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $109.2M | $117.7M | $-441.2M | $-540.3M | $364.5M | $363.3M | $368.2M | $701.3M | $717.0M | $781.8M | ||
Research & Development | $15.7M | $13.0M | $51.3M | $52.9M | $48.6M | $42.9M | $47.5M | $93.0M | $85.3M | $88.6M | ||
Research Expense | $15.7M | $13.0M | $51.3M | $52.9M | $48.6M | $42.9M | $47.5M | $93.0M | $85.3M | $88.6M | ||
Selling, General & Administrative | $83.2M | $89.4M | $304.0M | $320.0M | $277.0M | $284.0M | $302.6M | $608.3M | $606.7M | $638.8M | ||
Selling & Marketing Expenses | $-200.0K | $-100.0K | $304.0M | $320.0M | $100.0K | $200.0K | $200.0K | -- | -- | -- | ||
General & Administrative Expenses | $83.2M | $89.4M | $-7.9M | $-11.0M | $277.0M | $284.0M | $302.6M | $608.3M | $606.7M | $638.8M | ||
Promotion & Advertising | $-200.0K | $-100.0K | $-200.0K | $-600.0K | $100.0K | $200.0K | $200.0K | -- | -- | -- | ||
Salaries & Wages | $-12.8M | $-15.2M | $-19.4M | $-24.2M | $-4.8M | $-5.6M | $-6.4M | -- | -- | -- | ||
Depreciation & Amortization | $-15.9M | $-16.3M | $-51.6M | $-58.1M | $59.3M | $62.4M | $65.9M | $95.8M | $96.7M | $85.2M | ||
Depreciation & Amortization | $-15.9M | $-16.3M | $-51.6M | $-58.1M | $59.3M | $62.4M | $65.9M | -- | -- | -- | ||
Amortization | $-2.2M | $-2.8M | $-15.0M | $-16.6M | $211.4M | $197.6M | $189.0M | $1.5B | $1.5B | $1.4B | ||
Other Operating Expenses | $10.2M | $15.3M | $78.0M | $147.0M | $-86.3M | $-27.4M | $-18.2M | -- | -- | -- | ||
OPERATING INCOME | ||||||||||||
Operating income | $71.6M | $83.7M | $-7.1M | $50.2M | $107.4M | $98.2M | $123.2M | $-42.9M | $22.8M | $43.0M | ||
EBITDA | $89.4M | $105.7M | $120.0M | $98.4M | $200.9M | $184.9M | $257.7M | $249.0M | $274.4M | $277.4M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | -- | $118.0K | $2.0M | $709.0K | $549.0K | $1.8M | $-2.0M | $70.8M | $95.2M | $95.8M | ||
Intinc | -- | -- | $-2.5M | $-6.7M | -- | -- | $2.8M | -- | -- | -- | ||
Net Non-Operating Interest Income/Expense | -- | $-118.0K | $-4.5M | $-7.4M | $-549.0K | $-1.8M | $2.0M | $-66.4M | $-95.2M | $-95.8M | ||
Gain on Sale of Securities | -- | -- | -- | -- | $916.0K | $790.0K | $3.4M | -- | -- | -- | ||
Other Income/Expense | $1.9M | $-1.6M | $-62.9M | $20.4M | $-55.3M | $7.9M | $2.0M | $-44.5M | $-10.3M | $7.8M | ||
Other Special Charges | $1.1M | $885.0K | $8.0M | $20.4M | $7.9M | $1.1M | $-2.0M | $-5.1M | $-5.9M | $-13.2M | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | $-6.7M | $-800.0K | $-18.8M | $-4.5M | $8.4M | $7.9M | $-37.5M | -- | -- | -- | ||
Special Income Charges | $6.7M | $800.0K | $18.8M | $4.5M | $-8.4M | $-7.9M | $37.5M | $-9.7M | $2.6M | $327.0K | ||
Other Impairment Of Capital Assets | $4.1M | $728.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $69.7M | $85.3M | $53.3M | $23.1M | $115.3M | $154.1M | $157.5M | $-43.6M | $16.9M | $29.7M | ||
Pre-Tax Income | $69.7M | $85.2M | $51.3M | $22.4M | $114.7M | $152.4M | $159.5M | $-114.4M | $-37.0M | $-66.0M | ||
INCOME TAX | ||||||||||||
Tax Provision | $24.7M | $22.1M | $-17.4M | $-6.4M | $13.7M | $10.6M | $20.1M | $-40.1M | $-48.6M | $51.7M | ||
NET INCOME | ||||||||||||
Net Income | $45.0M | $63.1M | $68.6M | $28.8M | $101.0M | $86.9M | $103.1M | $-74.3M | $-29.7M | $-117.7M | ||
Net Income (Continuing Operations) | $45.0M | $63.1M | $68.6M | $28.8M | $101.0M | $86.9M | $139.5M | $-74.3M | $-29.7M | $-117.7M | ||
Net Income (Discontinued Operations) | $45.0M | $63.1M | $68.6M | $28.8M | $101.0M | $86.9M | $103.1M | $-74.3M | $-29.7M | $-117.7M | ||
Net Income (Common Stockholders) | $45.0M | $63.1M | $68.6M | $28.8M | $273.7M | $86.9M | $103.1M | $-74.3M | $-29.7M | $-117.7M | ||
TOTALS | ||||||||||||
Total Expenses | $270.1M | $295.7M | $-1.3B | $-1.4B | $1.2B | $1.2B | $1.2B | $2.3B | $2.2B | $2.3B | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $15.8M | $16.2M | $19.6M | $20.4M | $20.6M | $20.9M | $21.2M | $23.9M | $24.1M | $24.4M | ||
Average Shares Outstanding (Diluted) | $16.5M | $17.3M | $20.9M | $21.6M | $21.5M | $21.6M | $21.8M | $23.9M | $24.1M | $24.4M | ||
Shares Outstanding | $16.1M | $16.3M | $20.2M | $20.5M | $20.8M | $21.1M | $23.8M | $24.0M | $24.1M | $24.5M | ||
Basic EPS | $2.84 | $3.9 | $3.5 | $1.41 | $4.9 | $4.16 | $4.86 | $-3.11 | $-1.23 | $-4.83 | ||
Basic EPS (Continuing Operations) | $2.84 | $3.9 | -- | -- | $4.9 | $4.16 | $4.86 | $-3.11 | $-1.23 | $-4.83 | ||
Diluted EPS | $2.73 | $3.66 | $3.29 | $1.33 | $4.69 | $4.02 | $4.74 | $-3.11 | $-1.23 | $-4.83 | ||
Diluted EPS (Continuing Operations) | $2.73 | $3.66 | -- | -- | $4.69 | $4.02 | $4.74 | $-3.11 | $-1.23 | $-4.83 | ||
OTHER METRICS | ||||||||||||
Gain On Sale Of P P E | $1.1M | -- | -- | -- | -- | -- | $-1.7M | -- | -- | -- | ||
Other Gand A | $83.2M | $89.4M | $-7.9M | $-11.0M | $277.0M | $284.0M | $302.6M | $608.3M | $606.7M | $638.8M | ||
Rent And Landing Fees | $-400.0K | $-600.0K | $-7.9M | $-11.0M | -- | -- | -- | -- | -- | -- | ||
Selling Expense | -- | -- | $304.0M | $320.0M | -- | -- | -- | -- | -- | -- | ||
Restruct | $-6.7M | $-800.0K | $-18.8M | $-4.5M | $8.4M | $7.9M | $-37.5M | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | ICUI | $127.66 | +0.5% | 229.50K |
3 | ||||
4 | ||||
5 | ||||
6 |